Latest Breaking News On - Keytruda merck - Page 1 : comparemela.com

Ozempic hits booze sales, Moderna likes AI, Biogen's blockbuster drug

Plus, Bernie Sanders launches an investigation into Wegovy and Ozempic prices, and Bristol-Myers Squibb prepares to lose lucrative patents

Bristol-myers-squibb
Novartis
Astrazeneca
Wall-street
Biogen
Biogen
Moderna
Penai
Novartis
Merck
Wegovy

What made Moderna stock pop 10% on Tuesday?

What made Moderna stock pop 10% on Tuesday?
invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.

Keytruda-merck
Moderna-inc
Pfizer-inc
Invezz-signals
Respiratory-syncytial-virus

Investment Opportunities in the Biopharma Industry

The industry faces pressure from expiring patents, but we think innovation will offset these losses.

Eli-lilly
Keytruda-merck
Bristol-myers
Novo-nordisk
Johnson
Biopharma-companies-with-wide-moats
Bristol-myers-squibb
Companies-with-wide
Federal-trade-commission
Morningstar-economic-moat-rating
Key-therapeutic
Both-novo-nordisk

Moderna stock popped 15% on Thursday: explore why

Moderna stock popped 15% on Thursday: explore why
invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Stephane-bancel
Keytruda-merck
Moderna-inc
Merck-co-inc
American-cancer-society
Chief-executive

Scopus BioPharma's Subsidiary — Duet BioTherapeutics —

DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of.

United-states
Scopus-biopharma
Alan-horsager
Keytruda-merck
Marcin-kortylewski
David-waldman
Libtayo-regeneron
Opdivo-bristol-myers-squibb
Duet-biotherapeutics-inc
Company-form
Scopus-biopharma-inc
Crescendo-communications